HCA Midwest Health
April 06, 2018

Dr. Stephanie Graff discusses a new study, STRIVE, a test for early breast cancer detection.

STRIVE, a study sponsored by Grail, Inc., is seeking 120,000 women undergoing screening mammograms across participating sites, including the two Sarah Cannon Cancer Institute locations at Centerpoint and Menorah Medical Center. The simple blood test can enhance mammography screenings by identifying genetic material arising from tumors to help discover breast cancer at its earliest stages.